A nanoplasmonic biosensor for label-free multiplex detection of cancer biomarkers

Jong Uk Lee, Anh H. Nguyen, Sang Jun Sim

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The development of highly sensitive, selective and multiplex sensors has become an important challenge for disease diagnosis. In this study, we describe a multiplex biosensor for the detection of cancer biomarkers based on unique plasmon response of single gold nanoparticles (AuNPs) and antibody-antigen binding activity. To demonstrate the ability of the plasmon biosensor to detect and quantify cancer biomarkers: a panel of biomarkers, including α-fetoprotein (AFP), carcinoembryonic antigen (CEA) and prostate specific antigen (PSA) was used as a model analyte for multiple detection. A novel and sensitive multiplex biosensor was developed by immobilizing plasmonic nanoparticles in a site-specific manner and functionalized with monoclonal antibodies that recognize the target protein on hydrophilic-hydrophobic patterned glass slide. The proposed multi-analyte biosensor exhibited outstanding selectivity and sensitivity. The limit of detection was determined to be 91. fM, 94. fM and 10. fM for AFP, CEA and PSA from patient-mimicked serum, respectively. Finally, using this sensing strategy, this platform presents an excellent approach for versatile molecular diagnostics in both research and clinical medical fields.

Original languageEnglish
Pages (from-to)341-346
Number of pages6
JournalBiosensors and Bioelectronics
Volume74
DOIs
Publication statusPublished - 2015 Dec 5

Fingerprint

Biosensing Techniques
Antigens
Tumor Biomarkers
Biosensors
Labels
Carcinoembryonic Antigen
Prostate-Specific Antigen
Nanoparticles
Fetal Proteins
Molecular Pathology
Biomarkers
Monoclonal antibodies
Gold
Glass
Limit of Detection
Biomedical Research
Antibodies
Monoclonal Antibodies
Sensors
Proteins

Keywords

  • Cancer biomarkers
  • Gold nanoparticles
  • Localized surface plasmon resonance
  • Multiplex detection

ASJC Scopus subject areas

  • Biophysics
  • Biomedical Engineering
  • Biotechnology
  • Electrochemistry

Cite this

A nanoplasmonic biosensor for label-free multiplex detection of cancer biomarkers. / Lee, Jong Uk; Nguyen, Anh H.; Sim, Sang Jun.

In: Biosensors and Bioelectronics, Vol. 74, 05.12.2015, p. 341-346.

Research output: Contribution to journalArticle

@article{373dcd11098a4d5980347b26b9b6af89,
title = "A nanoplasmonic biosensor for label-free multiplex detection of cancer biomarkers",
abstract = "The development of highly sensitive, selective and multiplex sensors has become an important challenge for disease diagnosis. In this study, we describe a multiplex biosensor for the detection of cancer biomarkers based on unique plasmon response of single gold nanoparticles (AuNPs) and antibody-antigen binding activity. To demonstrate the ability of the plasmon biosensor to detect and quantify cancer biomarkers: a panel of biomarkers, including α-fetoprotein (AFP), carcinoembryonic antigen (CEA) and prostate specific antigen (PSA) was used as a model analyte for multiple detection. A novel and sensitive multiplex biosensor was developed by immobilizing plasmonic nanoparticles in a site-specific manner and functionalized with monoclonal antibodies that recognize the target protein on hydrophilic-hydrophobic patterned glass slide. The proposed multi-analyte biosensor exhibited outstanding selectivity and sensitivity. The limit of detection was determined to be 91. fM, 94. fM and 10. fM for AFP, CEA and PSA from patient-mimicked serum, respectively. Finally, using this sensing strategy, this platform presents an excellent approach for versatile molecular diagnostics in both research and clinical medical fields.",
keywords = "Cancer biomarkers, Gold nanoparticles, Localized surface plasmon resonance, Multiplex detection",
author = "Lee, {Jong Uk} and Nguyen, {Anh H.} and Sim, {Sang Jun}",
year = "2015",
month = "12",
day = "5",
doi = "10.1016/j.bios.2015.06.059",
language = "English",
volume = "74",
pages = "341--346",
journal = "Biosensors",
issn = "0956-5663",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - A nanoplasmonic biosensor for label-free multiplex detection of cancer biomarkers

AU - Lee, Jong Uk

AU - Nguyen, Anh H.

AU - Sim, Sang Jun

PY - 2015/12/5

Y1 - 2015/12/5

N2 - The development of highly sensitive, selective and multiplex sensors has become an important challenge for disease diagnosis. In this study, we describe a multiplex biosensor for the detection of cancer biomarkers based on unique plasmon response of single gold nanoparticles (AuNPs) and antibody-antigen binding activity. To demonstrate the ability of the plasmon biosensor to detect and quantify cancer biomarkers: a panel of biomarkers, including α-fetoprotein (AFP), carcinoembryonic antigen (CEA) and prostate specific antigen (PSA) was used as a model analyte for multiple detection. A novel and sensitive multiplex biosensor was developed by immobilizing plasmonic nanoparticles in a site-specific manner and functionalized with monoclonal antibodies that recognize the target protein on hydrophilic-hydrophobic patterned glass slide. The proposed multi-analyte biosensor exhibited outstanding selectivity and sensitivity. The limit of detection was determined to be 91. fM, 94. fM and 10. fM for AFP, CEA and PSA from patient-mimicked serum, respectively. Finally, using this sensing strategy, this platform presents an excellent approach for versatile molecular diagnostics in both research and clinical medical fields.

AB - The development of highly sensitive, selective and multiplex sensors has become an important challenge for disease diagnosis. In this study, we describe a multiplex biosensor for the detection of cancer biomarkers based on unique plasmon response of single gold nanoparticles (AuNPs) and antibody-antigen binding activity. To demonstrate the ability of the plasmon biosensor to detect and quantify cancer biomarkers: a panel of biomarkers, including α-fetoprotein (AFP), carcinoembryonic antigen (CEA) and prostate specific antigen (PSA) was used as a model analyte for multiple detection. A novel and sensitive multiplex biosensor was developed by immobilizing plasmonic nanoparticles in a site-specific manner and functionalized with monoclonal antibodies that recognize the target protein on hydrophilic-hydrophobic patterned glass slide. The proposed multi-analyte biosensor exhibited outstanding selectivity and sensitivity. The limit of detection was determined to be 91. fM, 94. fM and 10. fM for AFP, CEA and PSA from patient-mimicked serum, respectively. Finally, using this sensing strategy, this platform presents an excellent approach for versatile molecular diagnostics in both research and clinical medical fields.

KW - Cancer biomarkers

KW - Gold nanoparticles

KW - Localized surface plasmon resonance

KW - Multiplex detection

UR - http://www.scopus.com/inward/record.url?scp=84936774675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936774675&partnerID=8YFLogxK

U2 - 10.1016/j.bios.2015.06.059

DO - 10.1016/j.bios.2015.06.059

M3 - Article

C2 - 26159154

AN - SCOPUS:84936774675

VL - 74

SP - 341

EP - 346

JO - Biosensors

JF - Biosensors

SN - 0956-5663

ER -